Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

25-Hydroxyvitamin D Inhibits Hepatitis C Virus Production in Hepatocellular Carcinoma Cell Line by a Vitamin D Receptor-Independent Mechanism.

Ravid A, Rapaport N, Issachar A, Erman A, Bachmetov L, Tur-Kaspa R, Zemel R.

Int J Mol Sci. 2019 May 13;20(9). pii: E2367. doi: 10.3390/ijms20092367.

2.

A New Cutoff for Abnormal Proteinuria in Diabetes Mellitus Patients: Relationship to Albuminuria.

Erman O, Erman A, Vodonos A, Gafter U, van Dijk DJ.

Isr Med Assoc J. 2016 Jul;18(7):418-421.

3.

Effect of Acetazolamide on Obesity-Induced Glomerular Hyperfiltration: A Randomized Controlled Trial.

Zingerman B, Herman-Edelstein M, Erman A, Bar Sheshet Itach S, Ori Y, Rozen-Zvi B, Gafter U, Chagnac A.

PLoS One. 2015 Sep 14;10(9):e0137163. doi: 10.1371/journal.pone.0137163. eCollection 2015.

4.

An intradialytic increase in serum interleukin-6 levels is associated with an increased mortality in hemodialysis patients.

Lichtenberg S, Korzets A, Zingerman B, Green H, Erman A, Gafter U, Rozen-Zvi B.

Int J Artif Organs. 2015 May;38(5):237-43. doi: 10.5301/ijao.5000411. Epub 2015 Jun 2.

PMID:
26044660
5.

GFR in Patients with β-Thalassemia Major.

Milo G, Feige Gross Nevo R, Pazgal I, Gafter-Gvili A, Shpilberg O, Gafter U, Erman A, Stark P.

Clin J Am Soc Nephrol. 2015 Aug 7;10(8):1350-6. doi: 10.2215/CJN.12181214. Epub 2015 May 11.

6.

Changes in inflammatory markers during a hemodialysis session and their relation to vascular access type.

Rozen-Zvi B, Erman A, Korzets A, Levy-Drummer RS, Chagnac A, Khaskiya M, Zingerman B, Ori Y.

J Vasc Access. 2012 Oct-Dec;13(4):446-51. doi: 10.5301/jva.5000080.

PMID:
22729528
7.

Vitamin D: an innate antiviral agent suppressing hepatitis C virus in human hepatocytes.

Gal-Tanamy M, Bachmetov L, Ravid A, Koren R, Erman A, Tur-Kaspa R, Zemel R.

Hepatology. 2011 Nov;54(5):1570-9. doi: 10.1002/hep.24575.

PMID:
21793032
8.

The urine albumin-to-creatinine ratio: assessment of its performance in the renal transplant recipient population.

Erman A, Rahamimov R, Mashraki T, Levy-Drummer RS, Winkler J, David I, Hirsh Y, Gafter U, Chagnac A.

Clin J Am Soc Nephrol. 2011 Apr;6(4):892-7. doi: 10.2215/CJN.05280610. Epub 2011 Jan 6.

9.

Obesity-induced glomerular hyperfiltration: its involvement in the pathogenesis of tubular sodium reabsorption.

Chagnac A, Herman M, Zingerman B, Erman A, Rozen-Zvi B, Hirsh J, Gafter U.

Nephrol Dial Transplant. 2008 Dec;23(12):3946-52. doi: 10.1093/ndt/gfn379. Epub 2008 Jul 12.

PMID:
18622024
10.

Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.

Erman A, Veksler S, Gafter U, Boner G, Wittenberg C, van Dijk DJ.

J Renin Angiotensin Aldosterone Syst. 2004 Sep;5(3):146-51.

PMID:
15526251
11.

Coenzyme Q10 in patients with end-stage heart failure awaiting cardiac transplantation: a randomized, placebo-controlled study.

Berman M, Erman A, Ben-Gal T, Dvir D, Georghiou GP, Stamler A, Vered Y, Vidne BA, Aravot D.

Clin Cardiol. 2004 May;27(5):295-9.

12.

Insulin and losartan reduce proteinuria and renal hypertrophy in the pregnant diabetic rat.

Natif N, Sclarovsky-Benjaminov F, Van Dijk DJ, Sulkes J, Gafter U, Boner G, Erman A.

J Lab Clin Med. 2003 Sep;142(3):166-71.

PMID:
14532904
13.

Involvement of human heparanase in the pathogenesis of diabetic nephropathy.

Katz A, Van-Dijk DJ, Aingorn H, Erman A, Davies M, Darmon D, Hurvitz H, Vlodavsky I.

Isr Med Assoc J. 2002 Nov;4(11):996-1002.

14.

The contribution of an arteriovenous access for hemodialysis to left ventricular hypertrophy.

Ori Y, Korzets A, Katz M, Erman A, Weinstein T, Malachi T, Gafter U.

Am J Kidney Dis. 2002 Oct;40(4):745-52.

PMID:
12324909

Supplemental Content

Loading ...
Support Center